Literature DB >> 9699857

Molecular chaperones and subcellular trafficking of steroid receptors.

D B DeFranco1, C Ramakrishnan, Y Tang.   

Abstract

Unliganded steroid receptors exist as heteromeric complexes comprised of heat shock and immunophilin proteins that associate either directly or indirectly with receptor carboxyl-terminal ligand-binding domains. Molecular chaperons, and other proteins associated with steroid receptors, play an important role in the maturation of receptors to a hormone-binding competent state. Steroid receptor-associated 90 and 70 kDa heat shock proteins, hsp90 and hsp70, respectively, have well established roles in protein folding in addition to participating in numerous subcellular trafficking pathways. In this review, we discuss the possible roles that molecular chaperons, such as hsp90, hsp70 and DnaJ proteins, have in steroid receptor trafficking within two distinct subcellular compartments, i.e. the cytoplasm and nucleus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699857     DOI: 10.1016/s0960-0760(97)00177-5

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  12 in total

1.  The Hsp90 chaperone complex A potential target for cancer therapy?

Authors:  Beatrice D Darimont
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

2.  Ligand-independent activation of oestrogen receptor alpha by caveolin-1.

Authors:  A Schlegel; C Wang; R G Pestell; M P Lisanti
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

3.  Hsp90 inhibitor 17-AAG inhibits progression of LuCaP35 xenograft prostate tumors to castration resistance.

Authors:  Katherine J O'Malley; Gabrielle Langmann; Junkui Ai; Raquel Ramos-Garcia; Robert L Vessella; Zhou Wang
Journal:  Prostate       Date:  2011-12-07       Impact factor: 4.104

4.  The Hsp90 inhibitor, 17-AAG, prevents the ligand-independent nuclear localization of androgen receptor in refractory prostate cancer cells.

Authors:  Anthony J Saporita; Junkui Ai; Zhou Wang
Journal:  Prostate       Date:  2007-04-01       Impact factor: 4.104

Review 5.  Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Authors:  Jeff L Staudinger; Kristin Lichti
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

6.  Expression of inducible Hsp70 enhances the proliferation of MCF-7 breast cancer cells and protects against the cytotoxic effects of hyperthermia.

Authors:  J A Barnes; D J Dix; B W Collins; C Luft; J W Allen
Journal:  Cell Stress Chaperones       Date:  2001-10       Impact factor: 3.667

7.  The molecular chaperone Hsp90 can negatively regulate the activity of a glucocorticosteroid-dependent promoter.

Authors:  K I Kang; X Meng; J Devin-Leclerc; I Bouhouche; A Chadli; F Cadepond; E E Baulieu; M G Catelli
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  FKBP51 reciprocally regulates GRα and PPARγ activation via the Akt-p38 pathway.

Authors:  Lance A Stechschulte; Terry D Hinds; Simona S Ghanem; Weinian Shou; Sonia M Najjar; Edwin R Sanchez
Journal:  Mol Endocrinol       Date:  2014-06-16

9.  Estrogen receptor subtypes localization shifts in cultured mouse ovarian follicles.

Authors:  Sandy Lenie; Johan Smitz
Journal:  Histochem Cell Biol       Date:  2008-03-11       Impact factor: 4.304

10.  HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer.

Authors:  Junkui Ai; Yujuan Wang; Javid A Dar; June Liu; Lingqi Liu; Joel B Nelson; Zhou Wang
Journal:  Mol Endocrinol       Date:  2009-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.